Dexamethasone/Liposomal Doxorubicin/Etoposide/Ibrutinib/Rituximab/Temozolomide Regimen

**Semantic type:** Therapeutic or Preventive Procedure

**Definition:** A regimen consisting of dexamethasone, pegylated liposomal doxorubicin, etoposide, ibrutinib, rituximab and temozolomide that may be used in the treatment of central nervous system (CNS) lymphoma.

**Synonyms:** - Dexamethasone/Liposomal Doxorubicin/Etoposide/Ibrutinib/Rituximab/Temozolomide - TEDDI Plus Rituximab - TEDDI-R - TEDDI-R - TEDDI-R Regimen - Temozolomide/Etoposide/Doxil/Dexamethasone/Ibrutinib and Rituximab - Temozolomide/Etoposide/Doxil/Dexamethasone/Ibrutinib/Rituximab - Temozolomide/Etoposide/Doxil/Dexamethasone/Ibrutinib/Rituximab Regimen